CompletedPhase 2NCT00062114
Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
Studying Plasmablastic lymphoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Alliance for Clinical Trials in Oncology
- Principal Investigator
- Thomas C. Shea, MDUNC Lineberger Comprehensive Cancer Center
- Intervention
- rituximab(biological)
- Enrollment
- 84 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2004 – 2007
Study locations (30)
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
- Providence Saint Joseph Medical Center - Burbank, Burbank, California, United States
- Moores UCSD Cancer Center, La Jolla, California, United States
- Kaiser Permanente Medical Office -Vandever Medical Office, San Diego, California, United States
- Beebe Medical Center, Lewes, Delaware, United States
- CCOP - Christiana Care Health Services, Newark, Delaware, United States
- Rush-Copley Cancer Care Center, Aurora, Illinois, United States
- University of Illinois Cancer Center, Chicago, Illinois, United States
- University of Chicago Cancer Research Center, Chicago, Illinois, United States
- Joliet Oncology-Hematology Associates, Limited - West, Joliet, Illinois, United States
- Carle Cancer Center at Carle Foundation Hospital, Urbana, Illinois, United States
- CCOP - Carle Cancer Center, Urbana, Illinois, United States
- St. Francis Hospital and Health Centers - Beech Grove Campus, Beech Grove, Indiana, United States
- Saint Anthony Memorial Health Centers, Michigan City, Indiana, United States
- Reid Hospital & Health Care Services, Incorporated, Richmond, Indiana, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00062114 on ClinicalTrials.govOther trials for Plasmablastic lymphoma
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06781359Study on Plasmablastic Lymphoma PatientsFondazione Italiana Linfomi - ETS
- RECRUITINGPHASE2NCT04915248Study to Evaluate Combined Treatment of Daratumumab, Bortezomib and Dexamethasone in PBL Patients.Fondazione Italiana Linfomi - ETS
- RECRUITINGEARLY PHASE1NCT04139304A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic LymphomaAIDS Malignancy Consortium
- ACTIVE NOT RECRUITINGPHASE1NCT01961063Gene Therapy After Frontline Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin LymphomaCity of Hope Medical Center